Strides Pharma Science Ltd
NSE:STAR

Watchlist Manager
Strides Pharma Science Ltd Logo
Strides Pharma Science Ltd
NSE:STAR
Watchlist
Price: 726.05 INR 3.4% Market Closed
Market Cap: 66.9B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+27%
Revenue
Forecast
+16%
Operating Income
Forecast
+25%
Net Income
Forecast
+39%

Wall Street
Price Targets

STAR Price Targets Summary
Strides Pharma Science Ltd

Wall Street analysts forecast STAR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STAR is 1 463.7 INR with a low forecast of 1 080.7 INR and a high forecast of 1 890 INR.

STAR Lowest Forecast
Wall Street Target
1 080.7 INR
49% Upside
STAR Average Forecast
Wall Street Target
1 463.7 INR
102% Upside
STAR Highest Forecast
Wall Street Target
1 890 INR
160% Upside
Lowest
Price Target
1 080.7 INR
49% Upside
Average
Price Target
1 463.7 INR
102% Upside
Highest
Price Target
1 890 INR
160% Upside
Strides Pharma Science Ltd Competitors:
Price Targets
CIPLA
Cipla Ltd
9% Upside
1477
Ocumension Therapeutics
48% Upside
MEDCL
Medincell SA
50% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
49% Upside
CIPLA
Cipla Ltd
9% Upside
1477
Ocumension Therapeutics
48% Upside
MEDCL
Medincell SA
50% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
49% Upside
4519
Chugai Pharmaceutical Co Ltd
19% Upside
H
293480
Hana Pharm Co Ltd
74% Upside
P
300363
Porton Pharma Solutions Ltd
25% Upside
Z
002332
Zhejiang Xianju Pharmaceutical Co Ltd
69% Upside

Revenue
Forecast

Revenue Estimate
Strides Pharma Science Ltd

For the last 8 years the compound annual growth rate for Strides Pharma Science Ltd's revenue is 4%. The projected CAGR for the next 3 years is 13%.

4%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Strides Pharma Science Ltd

For the last 8 years the compound annual growth rate for Strides Pharma Science Ltd's operating income is 7%. The projected CAGR for the next 3 years is 28%.

7%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-18%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Strides Pharma Science Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
What are analyst estimates?

See Also

Summary
STAR intrinsic value, competitors valuation, and company profile.
DCF Valuation
STAR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
STAR stock valuation using valuation multiples.
Wall Street Estimates
STAR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
STAR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is STAR's stock price target?
Price Target
1 463.7 INR

According to Wall Street analysts, the average 1-year price target for STAR is 1 463.7 INR with a low forecast of 1 080.7 INR and a high forecast of 1 890 INR.

What is Strides Pharma Science Ltd's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Strides Pharma Science Ltd's revenue is 4%. The projected CAGR for the next 3 years is 13%.

What is Strides Pharma Science Ltd's Operating Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Strides Pharma Science Ltd's operating income is 7%. The projected CAGR for the next 3 years is 28%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.